Showing 1-4 of 4 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| NKG2D Signaling as a Critical Modulator of Autoreactive CD8⁺ T Cell Differentiation and β Cell Destruction in Type 1 Diabetes | University of Kansas Medical Center Research Institute, Inc. | Ambika Dudhate | Cures | 01-March-2026 to 28-February-2029 | $274,010.00 |
| Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets | University of Kansas Medical Center Research Institute, Inc. | Hubert Tse | Cures | 01-April-2024 to 30-November-2026 | $599,998.25 |
| Engineering a novel Treg population to control autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-April-2025 to 31-December-2026 | $199,999.62 |
| Determining how NKG2D signaling drives autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-September-2023 to 31-August-2026 | $750,000.00 |